Citation: J. Rohmel, REEVALUATION OF DECISIONS ON THE RECOMMENDED DOSE FROM PHASE-III DOSE-FINDING TRIALS, Statistics in medicine, 14(9-10), 1995, pp. 895-895
Authors:
MAURER W
WHITEHEAD J
ROHMEL J
DERZKO G
HUCHER M
BAUER P
Citation: W. Maurer et al., REEVALUATION OF DECISIONS ON THE RECOMMENDED DOSE FROM PHASE-III DOSE-FINDING TRIALS - DISCUSSION, Statistics in medicine, 14(9-10), 1995, pp. 897-899
Citation: F. Mentre et al., INFERRING SYSTEMIC EXPOSURE FROM A PHARMACOKINETIC SCREEN - MODEL-FREE AND MODEL-BASED APPROACHES - DISCUSSION, Statistics in medicine, 14(9-10), 1995, pp. 969-970
Authors:
DAGOSTINO R
ROHMEL J
GOULD L
DERZKO G
JONES B
EZZET F
Citation: R. Dagostino et al., CHOOSING THE DESIGN OF A CONFIRMATORY CLINICAL-TRIAL - DISCUSSION, Statistics in medicine, 14(9-10), 1995, pp. 1053-1055
Citation: J. Rohmel et G. Derzko, CHOOSING THE DESIGN OF A CONFIRMATORY CLINICAL-TRIAL - DISCUSSION, Statistics in medicine, 14(9-10), 1995, pp. 1065-1065
Citation: E. Garbe et al., CLINICAL AND STATISTICAL ISSUES IN THERAPEUTIC EQUIVALENCE TRIALS, European Journal of Clinical Pharmacology, 45(1), 1993, pp. 1-7